Other benefits
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum, a season ticket loan scheme and access to a comprehensive range of development opportunities. Reasonable adjustments will be made for any candidate with a disability.
Vacancy details
Wolfson Institute of Population Health/Preventive Neurology Unit
Clinical Research Scientist (KTP Associate)
QMUL 29159
About the Role
This post will focus on the clinical validation of the CUE1 medical device (feasibility, efficacy and tolerability). CUE1 is a vibrotactile stimulation device for alleviating symptoms of Parkinson's disease (PD). It is funded by a new Knowledge Transfer Partnership (KTP) grant awarded to researchers at Queen Mary University of London (QMUL) and Charco Neurotech by Innovate UK (part of UKRI).
The information generated from this exciting project will enable the design of a formal clinical trial to assess and validate the device in treating drug-resistant symptoms of PD. This cutting-edge technology aims to improve quality of life for patients with PD.
This is a hybrid working role. Up to 75% of the time can be remote, for which Charco will be providing a laptop for communication. Charco’s supervision will involve daily support from relevant team members.
In person attendance at Charco's office will be required at least once-a-month along with the attendance to the management committee meeting once every 4 months. The rest of the time will be spent working in the Preventive Neurology Unit (PNU), at the Wolfson Institute of Population Health, QMUL, and in the Neurology Department at the Royal London Hospital, Barts Health NHS Trust.
The successful candidate will receive extensive training from academic and industry supervisors; gaining clinical skills, and broadening their knowledge and expertise. The KTP Associate will also benefit from a substantial Personal Development Budget.
About You
Candidates must have a Professional degree (MB BS for doctors or equivalent for AHPs) and a BSc or Master’s degree in a science subject or equivalent experience. Understanding of the research process and broad knowledge of the conduct of clinical research are essential. To deliver this project successfully, we expect that the applicant has some clinical background in PD and possess clinical qualifications and skills that are commensurate with their career stage.
About the Centre
The Centre for Prevention, Detection and Diagnosis is at the forefront of international research into the prevention and control of neurological disease and cancer. The PNU has particularly active research programmes in multiple sclerosis, Parkinson’s disease and dementia.
About Queen Mary
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
The post is a full time fixed term appointment for 2 years. Starting salary will be in the range of NHS Professional Grade Band 7 – 8a (£40,057 - £53,219) or Junior Doctor CT1-ST5 (£40,257 - £51,017) annum plus London Allowance.
The work location will be 75% remote, 25% in person (20% London and 5% Cambridge).
Informal enquiries should be addressed to Dr Cristina Simonet and/ or Dr Alastair Noyce
c.simonet@qmul.ac.uk, a.noyce@qmul.ac.uk
Details about the Institute can be found at https://www.qmul.ac.uk/wiph/centres/centre-for-
prevention-detection-and-diagnosis/
How to apply
The closing date for applications is 21 September 2022. Interviews will be held shortly thereafter.
Valuing Diversity & Committed to Equality